Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,76 USD | +0,73 % | -1,08 % | +19,48 % |
Resumen de negocios
Número de empleados: 33
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rare Disease Therapies
100,0
%
| 0 | nan % | 12 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01/03/15 |
Founder | 64 | 10/07/15 | |
Charles Sermon
FOU | Founder | 55 | 01/03/15 |
Christine Fox
DFI | Director of Finance/CFO | 43 | 31/01/21 |
Michael Wyzga
CHM | Chairman | 69 | 23/04/19 |
Suba Krishnan
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/12/20 |
John Lewicki
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/07/20 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01/08/19 |
Corporate Officer/Principal | 53 | 01/03/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23/04/19 |
Director/Board Member | - | 10/11/22 | |
Director/Board Member | 59 | 23/04/19 | |
Founder | 64 | 10/07/15 | |
Director/Board Member | 70 | 01/07/15 | |
Pierre Jacquet
BRD | Director/Board Member | 57 | 20/09/21 |
Justin Roberts
BRD | Director/Board Member | - | 10/11/22 |
Annalisa Jenkins
BRD | Director/Board Member | 58 | 10/11/22 |
Jeremy Bender
BRD | Director/Board Member | 52 | 01/10/20 |
Daniel Shames
BRD | Director/Board Member | - | 10/11/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 643 204 794 | 301 926 833 ( 46,94 %) | 0 | 46,94 % |
Información de la empresa
Mereo BioPharma Group Plc
1 Cavendish Place 4th Floor
W1G 0QF, London
+44 33 3023 7300
http://www.mereobiopharma.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+19,48 % | 386 M | |
-2,63 % | 102 mil M | |
+1,62 % | 96,29 mil M | |
+1,98 % | 22,18 mil M | |
-16,67 % | 21,2 mil M | |
-8,68 % | 18,31 mil M | |
-38,74 % | 17,38 mil M | |
-13,21 % | 16,36 mil M | |
+5,41 % | 13,97 mil M | |
+33,57 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción MREO
- Empresa Mereo BioPharma Group plc